677 related articles for article (PubMed ID: 15148141)
1. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
Arvanitakis Z; Wilson RS; Bienias JL; Evans DA; Bennett DA
Arch Neurol; 2004 May; 61(5):661-6. PubMed ID: 15148141
[TBL] [Abstract][Full Text] [Related]
2. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
3. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.
Wilson RS; Schneider JA; Bienias JL; Evans DA; Bennett DA
Arch Neurol; 2003 Apr; 60(4):539-44. PubMed ID: 12707067
[TBL] [Abstract][Full Text] [Related]
4. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
Boyle PA; Wilson RS; Aggarwal NT; Tang Y; Bennett DA
Neurology; 2006 Aug; 67(3):441-5. PubMed ID: 16894105
[TBL] [Abstract][Full Text] [Related]
5. Change in body mass index and risk of incident Alzheimer disease.
Buchman AS; Wilson RS; Bienias JL; Shah RC; Evans DA; Bennett DA
Neurology; 2005 Sep; 65(6):892-7. PubMed ID: 16186530
[TBL] [Abstract][Full Text] [Related]
6. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
7. Neuropathology of older persons without cognitive impairment from two community-based studies.
Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
[TBL] [Abstract][Full Text] [Related]
8. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly.
Buchman AS; Boyle PA; Wilson RS; Tang Y; Bennett DA
Psychosom Med; 2007 Jun; 69(5):483-9. PubMed ID: 17556640
[TBL] [Abstract][Full Text] [Related]
9. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
10. Loneliness and risk of Alzheimer disease.
Wilson RS; Krueger KR; Arnold SE; Schneider JA; Kelly JF; Barnes LL; Tang Y; Bennett DA
Arch Gen Psychiatry; 2007 Feb; 64(2):234-40. PubMed ID: 17283291
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the clinical manifestations of Alzheimer disease pathology.
Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
13. Diabetes is related to cerebral infarction but not to AD pathology in older persons.
Arvanitakis Z; Schneider JA; Wilson RS; Li Y; Arnold SE; Wang Z; Bennett DA
Neurology; 2006 Dec; 67(11):1960-5. PubMed ID: 17159101
[TBL] [Abstract][Full Text] [Related]
14. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
15. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
[TBL] [Abstract][Full Text] [Related]
16. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.
Holtzer R; Wegesin DJ; Albert SM; Marder K; Bell K; Albert M; Brandt J; Stern Y
Arch Neurol; 2003 Aug; 60(8):1137-42. PubMed ID: 12925372
[TBL] [Abstract][Full Text] [Related]
17. Relation of cognitive activity to risk of developing Alzheimer disease.
Wilson RS; Scherr PA; Schneider JA; Tang Y; Bennett DA
Neurology; 2007 Nov; 69(20):1911-20. PubMed ID: 17596582
[TBL] [Abstract][Full Text] [Related]
18. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
19. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.
Plastino M; Fava A; Pirritano D; Cotronei P; Sacco N; Sperlì T; Spanò A; Gallo D; Mungari P; Consoli D; Bosco D
J Neurol Sci; 2010 Jan; 288(1-2):112-6. PubMed ID: 19836029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
